PubMed ID:
33257421
Public Release Type:
Journal
Publication Year: 2020
Affiliation: Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.; Department of Medicine, Division of Endocrinology, Diabetes & Metabolism, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Alpert Medical School of Brown University, Providence, Rhode Island, USA.; Department of Medicine, Division of Endocrinology, Diabetes & Metabolism, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Department of Medicine, Division of Endocrinology, Diabetes & Metabolism, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA jechouf1@jhmi.edu.
DOI:
https://doi.org/10.1136/bmjdrc-2020-001753
Authors:
Kaze Arnaud D, Santhanam Prasanna, Erqou Sebhat, Ahima Rexford S, Echouffo-Tcheugui Justin Basile
Request IDs:
22606
Studies:
Look AHEAD: Action for Health in Diabetes
Glycemic variability may predict poor outcomes in type 2 diabetes. We evaluated the associations of long-term variability in glycosylated hemoglobin (HbA1C) and fasting plasma glucose (FPG) with cardiovascular disease (CVD) and death among individuals with type 2 diabetes.